Other
Is big tech good for your health?
- Digital biomarkers and linked patient data are projected to significantly impact medicine by enabling pattern recognition for care efficiency and error identification, despite healthcare systems currently lagging approximately ten years behind other sectors in modern technology adoption.
- Inefficiencies and underutilization of digital tools are estimated to cost wealthy nations up to $600 billion annually, representing roughly 8% of current health spending, while aging populations and reduced funding create financial barriers for necessary digital reorganization.
- Major technology corporations have outlined specific strategic initiatives: Microsoft plans to supply AI tools for analyzing surgical and cancer therapy outcomes; Google intends to facilitate patient data searches with Ascension and identify high-risk hospital patients with the Royal Free; Amazon is forming a new healthcare company with Berkshire Hathaway and JPMorgan; Apple will utilize the Research app for academic medical studies; and Verily aims to establish a global health data repository and "ground truth" through Project Baseline.
- Verily, alongside individual participant Camilo Barcines, plans to collect clinical, behavioral, psychological, and molecular data over a four-year period to establish comprehensive health baselines and predict disease before symptoms manifest, anticipating this data will become a multi-trillion dollar asset for the healthcare market.
- Conflicts regarding patient privacy are expected between medical professionals and advertising entities, prompting forecasts that governments must lead in ensuring data protection and transparency to mitigate public fears about big tech access to medical records.
- Health systems that integrate technology are forecast to improve care, save lives, and reduce costs, whereas failure to develop these capabilities internally or welcome tech partnerships is feared to result in a significant cost in human life.